Literature DB >> 19800248

A new endovascular size reducer for large pulmonary outflow tract.

Brahim Amahzoune1, Catherine Szymansky, Jean-Noël Fabiani, Rachid Zegdi.   

Abstract

Around 75% of patients with severe pulmonary insufficiency requiring valvular replacement are excluded from percutaneous pulmonary valve implantation (PPVI) due to a large ventricular outflow tract. To extend the indication of PPVI to these patients, a new size reducer has been designed. This 35-mm size reducer was successfully deployed inside the main pulmonary artery through a 21-Fr delivery catheter in six sheep. A 20-mm pericardial valved stent was subsequently deployed inside the size reducer to restore pulmonary valve continence. We successfully verified the efficiency of the delivery catheter by controlling the deployment precisely and reversibly. In all six cases, device positioning was satisfactory. There was no post-procedural residual stenosis in the right ventricular outflow tract in haemodynamic (9.5+/-3 mm Hg), echocardiographic and angiographic studies. After 8-12 weeks of follow-up, no prosthetic migration occurred. The transprosthetic systolic gradient remained low (4+/-2.5 mm Hg) during follow-up. There was one trivial persistent paraprosthetic leak. This study confirmed the feasibility and the effectiveness of this new size reducer to reduce the size of the pulmonary artery. Copyright (c) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19800248     DOI: 10.1016/j.ejcts.2009.08.034

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

Review 1.  Will catheter interventions replace surgery for valve abnormalities?

Authors:  Michael L O'Byrne; Matthew J Gillespie
Journal:  Curr Opin Cardiol       Date:  2014-01       Impact factor: 2.161

2.  Single-Barrel, Double-Barrel, and Fenestrated Endografts to Facilitate Transcatheter Pulmonary Valve Replacement in Large RVOT.

Authors:  Norihiko Kamioka; Vasilis C Babaliaros; John C Lisko; Anurag Sahu; Subhadra Shashidharan; Matthew R Carazo; Maan Jokhadar; Fred H Rodriguez; Wendy M Book; Patrick T Gleason; William B Keeling; Wissam Jaber; Peter C Block; Robert J Lederman; Adam B Greenbaum; Dennis W Kim
Journal:  JACC Cardiovasc Interv       Date:  2020-12-14       Impact factor: 11.195

3.  Outcomes of Venus P-valve for dysfunctional right ventricular outflow tracts from Indian Venus P-valve database.

Authors:  Kothandam Sivakumar; Pramod Sagar; Shakeel Qureshi; Worakan Promphan; Bijulal Sasidharan; Neeraj Awasthy; Mahesh Kappanayil; Pujar Venkatesh Suresh; Nageswara Rao Koneti
Journal:  Ann Pediatr Cardiol       Date:  2021-08-26

Review 4.  Recent advances in cardiac catheterization for congenital heart disease.

Authors:  Sok-Leng Kang; Lee Benson
Journal:  F1000Res       Date:  2018-03-26

Review 5.  Tissue Engineered Transcatheter Pulmonary Valved Stent Implantation: Current State and Future Prospect.

Authors:  Xiling Zhang; Thomas Puehler; Jette Seiler; Stanislav N Gorb; Janarthanan Sathananthan; Stephanie Sellers; Assad Haneya; Jan-Hinnerk Hansen; Anselm Uebing; Oliver J Müller; Derk Frank; Georg Lutter
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.